HSPA2 and diabetes mellitus: By assessing myocardial transcriptomic hits in their circulating protein form, we validated lower ERBB3 and higher HSPA2 in people with diabetes and found these to be associated with LV dysfunction, incident HF, and cardiovascular mortality.